In addition, the diagnostic accuracy of [68Ga]Ga-PSMA-11 PET for detecting clinically significant PCa returned pooled sensitivity and negative likelihood ratios of 0.99 and 0.02, respectively, implying a potential role as a non-invasive risk stratifier [33]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.